View Older Stories

Jun 24, 2026 03:37PM Cosmos Health antiseptic product nears $1.3M in annualized sales in Greece

Jun 22, 2026 10:30AM Cosmos Health unit secures 25M-unit manufacturing orderbook

Jun 18, 2026 03:42PM CosmoFarm posts record Q2 2026 revenue above $15M

Jun 17, 2026 03:37PM Cosmos Health launches Korean collagen skincare line in the U.S.

Jun 15, 2026 09:00AM Cosmos Health projects over $22.7M revenue from four US products

Jun 12, 2026 09:29AM Cosmos Health reports $1.5m in antiseptic brand sales, eyes EU expansion

Jun 10, 2026 09:00AM Cosmos Health reports record $65.3M revenue, targets $200M by 2029

Jun 9, 2026 03:31PM Cosmos Health secures 5-year CERTORUN manufacturing deal worth 385,000 units

Jun 8, 2026 06:05AM Cosmos Health (COSM) files $200M mixed shelf

Jun 5, 2026 09:26AM Cosmos Health launches Oliv18 supplement in the US market

Jun 4, 2026 03:58PM Cosmos Health expands Sky Premium Life to all 27 EU states via Skroutz

Jun 4, 2026 09:28AM Cosmos Health identifies $20 million in non-core assets for potential sale

Jun 2, 2026 08:00AM Cosmos Health discusses European Investment Bank financing talks

Jun 1, 2026 08:27AM Cosmos Health enters animal health market with C-Scrub wash

May 26, 2026 09:34AM Cosmos Health issues 2026-2029 guidance targeting $200m revenue by 2029

May 21, 2026 02:27PM Cosmos Health lets 4.87 million Series B warrants expire unexercised

May 21, 2026 02:20PM Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

May 21, 2026 09:16AM Cosmos Health reports record Q1 revenue of $17.9 million, up 31%

May 21, 2026 09:15AM Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with

May 14, 2026 09:03AM Cosmos Health secures advisory deal with European Investment Bank

May 14, 2026 09:00AM Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents

May 12, 2026 10:15AM Cosmos Health withdraws SEC registration statement for public offering

May 12, 2026 10:15AM Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

May 11, 2026 02:58PM Cosmos Health projects $3.2M revenue from Fort18 supplement launch

May 11, 2026 02:25PM Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

May 8, 2026 11:25AM Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

May 6, 2026 10:35AM Cosmos Health launches Fort18 supplement for men's sexual stamina in US

May 6, 2026 10:35AM Cosmos Health Introduces Fort18 in the United States - A Men's Sexual Stamina Supplement Expanding the 18 Series into Men's Wellness

Apr 30, 2026 12:50PM Cosmos Health projects $2.5 million revenue from Cur18 supplement

Apr 30, 2026 12:50PM Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Apr 21, 2026 12:50PM Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting

Apr 20, 2026 10:55AM Cosmos Health completes Liv18 development, eyes $5M annual revenue

Apr 20, 2026 10:55AM Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Co

Apr 17, 2026 02:00PM Cosmos Health plans US launch of enhanced curcumin supplement in Q2

Apr 17, 2026 02:00PM Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint

Apr 16, 2026 03:15PM Cosmos Health deploys AI across operations, targets 30% cost reduction

Apr 16, 2026 03:15PM Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

Apr 15, 2026 09:25AM Cosmos Health reports record revenue of $65.3 million for 2025

Apr 15, 2026 09:25AM Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash P

Apr 13, 2026 12:50PM Cosmos Health receives third order from Pharmalink for 60,000 units

Apr 13, 2026 12:50PM Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3

Apr 10, 2026 09:42AM Cosmos Health reports no Middle East conflict impact, targets $12M US revenue

Apr 10, 2026 09:40AM Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months

Apr 8, 2026 11:10AM Cosmos Health plans Q2 launch of liver supplement Liv18 in US

Apr 8, 2026 11:10AM Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction

Apr 1, 2026 11:42AM Cosmos Health's C-Scrub Wash 4% passes European surgical disinfection test

Apr 1, 2026 11:42AM Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets

Mar 19, 2026 12:45PM Cosmos Health projects $12M+ revenue from U.S. expansion

Mar 11, 2026 01:45PM Cosmos Health buys $600,000 in bitcoin, digital assets reach $3.1 million

Feb 18, 2026 01:45PM Cosmos Health expands C-Scrub to Superdrug stores across UK

View Older Stories